Breast Cancer Awareness Month
CSOFT Life Sciences has over 15 years of experience providing end-to-end translation and localization solutions for all stages of the product life cycle, from pre-clinical to post-launch. We also specialize in China market access consulting services, Asian regulatory and eCTD submissions. Our operation is compliant with ISO 17100 and certified by BSI in ISO 9001:2015 and ISO 13485:2016, providing customized solutions to meet the rigorous regulatory requirements in global submission. For more information, please visit: www.csoftintl.com
What is Breast Cancer?
Breast cancer is a disease where breast cells grow uncontrollably and can spread through the blood and lymph vessels. Cancer develops when the human’s genetic growth is messed up. Usually, cell growth occurs in a sequence, but when that sequence is disrupted, the cells can keep dividing and spread throughout the body system. These cells gather together to create a tumor that can either be life-threatening or non-dangerous.
Breast Cancer Awareness Month takes place in October, where people hold annual campaign to help increase awareness of the disease. The WHO reported that there are 458,000 deaths solely from breast cancer each year. It is important to raise awareness in developing countries, where women in the low and middle class with breast cancer lacked the awareness for early detection and access to proper health services. Another reason why people are raising awareness for those that are living in the developing countries is because therapies and clinical examination are very costly for those that are unable to afford it.
Identifying and Reducing Risks
Symptoms of breast cancer:
- Lumps/swelling in the breast, upper chest, or armpit
- Skin, nipples, and breast changes texture and colors
- Rash around the nipple area
- Unusual discharge
Ways to reduce risks:
- Maintaining healthy
- Weight Exercising
- Replacing therapy
- Decrease alcohol consumption
The most common type of treatments is chemotherapy, radiation therapy, hormone therapy, surgery, and biologics therapy. In March 2019, the FDA approved a new innovative immunotherapy drug called atezolizumab, which targets the PD-L1 protein to wipe out the cancer cells. This treatment is available for patients with triple negative breast cancer (more aggressive than other types of breast cancer). The triple-negative breast cancer will spread beyond the chest area. This cancer type is very persistent, meaning that it will target the patient after 3 years of treatment and more deadly if it comes back after 5 years. Immunotherapy’s side effects are less powerful than chemotherapy. Depending on the body type, the following side effects may or may not occur. Common effects are feeling tired/fatigued, diarrhea, high fever, shortness of breath, rashes covering the body, nausea, vomiting, and itching.
Breast Cancer Awareness Month. (n.d.). Retrieved from https://www.nationalbreastcancer.org/breast-cancer-awarenessmonth.
Breast Cancer Awareness Month in October. (2012, October 16). Retrieved from https://www.who.int/cancer/events/breast_cancer_month/en/.
Emens, L. A. (n.d.). Immunotherapy for Breast Cancer. Retrieved from http://www.cancerresearch.org/immunotherapy/cancer-types/breastcancer.
What Is Breast Cancer? (2018, May 18). Retrieved October 9, 2019, from https://www.breastcancer.org/symptoms/understand_bc/what_is_bc.